For more information or confidential assistance
se habla español

Xarelto MDL Continues to Grow

The Xarelto multidistrict litigation in Louisiana continues to grow, as another lawsuit was added to the ongoing proceedings on February 11. Estella Roethler filed a lawsuit individually and as the representative of the estate of Augustina Asocar Rodriguez. Rodriguez was prescribed and ingested the blood thinning medication from approximately January... Read more »

Study Suggests Xarelto Presents Greater Risk for Kidney Patients

According to recently-released research findings, next-generation blood-thinning drug Xarelto may pose additional risk to patients who are already suffering from kidney disease. The study, based on data taken from the Department of Defense electronic medical records system, found that those with existing kidney ailments were significantly more likely to experience... Read more »

Several Claims Added to Xarelto MDL

On December 2, 2015, six additional claimants added their causes of action to the pending multidistrict litigation (MDL) involving the blood-thinning drug Xarelto. Xarelto, which is also known rivaroxaban, is a relatively new blood thinning drug touted to offer patients an increased level of convenience as they treat their underlying... Read more »

Xarelto Internal Bleeding Lawsuit Adds 5 Plaintiffs to MDL

On August 7, 2015, five plaintiffs from as many states filed a joint complaint adding a Xarelto internal bleeding lawsuit to ongoing multi-district litigation (“MDL”). There are more than 500 Xarelto lawsuits already included in the MDL. The complex litigation is being overseen by U.S. District Judge Eldon Fallon in... Read more »